• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病患者基质金属蛋白酶-2、基质金属蛋白酶-9、金属蛋白酶组织抑制剂-1的表达及肺泡间隔变化

Expression of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, and Changes in Alveolar Septa in Patients with Chronic Obstructive Pulmonary Disease.

作者信息

Zhang Yongxiang, Li Yuechuan, Ye Zhen, Ma Hui

机构信息

Department of Respiratory and Critical Care Medicine, Tianjin Chest Hospital, Tianjin, China (mainland).

出版信息

Med Sci Monit. 2020 Oct 18;26:e925278. doi: 10.12659/MSM.925278.

DOI:10.12659/MSM.925278
PMID:33070147
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7580176/
Abstract

BACKGROUND This study investigated the relationship between the pathological alteration of alveolar septa and (1) pulmonary function and (2) matrix metalloproteinase (MMP)-2, MMP-9, and tissue inhibitor matrix metalloproteinase 1 (TIMP-1) expression in chronic obstructive pulmonary disease (COPD). MATERIAL AND METHODS Sixty patients with pulmonary disease were divided into control (n=20) and COPD (n=40) groups. Postoperative lung tissue specimens were examined. Hematoxylin and eosin and elastin van Gieson staining detected pathological alterations of pulmonary alveolar septa. Septa thickness was measured. MMP-2, MMP-9, and TIMP-1 expression levels were detected by immunohistochemical staining. Correlations were determined by Pearson analysis. RESULTS Forced expiratory volume in 1 s (FEV₁), forced vital capacity, FEV₁ percent predicted (FEV₁%pre), and diffusion capacity of carbon monoxide percent predicted (DLCO%pre) in COPD patients were significantly lower than in those of the control group (P<0.05). MMP-2, MMP-9, and TIMP-1 expression levels were significantly higher in the COPD group than in control, especially the severe group (P<0.05). Septa thickness was negatively correlated with FEV₁%pre (r=-0.335; P<0.05) and positively correlated with MMP-2 and TIMP-1 expression (P<0.05). Proportion of collagenous fiber was negatively correlated with FEV₁%pre and DLCO%pre (P<0.01), and positively correlated with MMP-2, MMP-9, and TIMP-1 expression (P<0.01). Proportion of elastic fibers was negatively correlated with collagenous fiber. CONCLUSIONS The pathological alteration of alveolar septa was correlated with pulmonary function and expression levels of MMP-2, MMP-9, and TIMP-1, which can play vital roles in COPD progression.

摘要

背景 本研究调查了慢性阻塞性肺疾病(COPD)中肺泡间隔的病理改变与(1)肺功能以及(2)基质金属蛋白酶(MMP)-2、MMP-9和基质金属蛋白酶组织抑制剂1(TIMP-1)表达之间的关系。材料与方法 将60例肺部疾病患者分为对照组(n = 20)和COPD组(n = 40)。对术后肺组织标本进行检查。苏木精-伊红染色和弹性蛋白-范吉森染色检测肺泡间隔的病理改变。测量间隔厚度。通过免疫组织化学染色检测MMP-2、MMP-9和TIMP-1的表达水平。采用Pearson分析确定相关性。结果 COPD患者的第1秒用力呼气容积(FEV₁)、用力肺活量、预测FEV₁百分比(FEV₁%pre)和预测一氧化碳弥散量百分比(DLCO%pre)显著低于对照组(P<0.05)。COPD组中MMP-2、MMP-9和TIMP-1的表达水平显著高于对照组,尤其是重度组(P<0.05)。间隔厚度与FEV₁%pre呈负相关(r = -0.335;P<0.05),与MMP-2和TIMP-1表达呈正相关(P<0.05)。胶原纤维比例与FEV₁%pre和DLCO%pre呈负相关(P<0.01),与MMP-2、MMP-9和TIMP-1表达呈正相关(P<0.01)。弹性纤维比例与胶原纤维呈负相关。结论 肺泡间隔的病理改变与肺功能以及MMP-2、MMP-9和TIMP-1的表达水平相关,它们在COPD进展中可能起重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82cc/7580176/1ce3cce26f49/medscimonit-26-e925278-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82cc/7580176/f43c8e252ae3/medscimonit-26-e925278-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82cc/7580176/63ba804a80f9/medscimonit-26-e925278-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82cc/7580176/1ce3cce26f49/medscimonit-26-e925278-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82cc/7580176/f43c8e252ae3/medscimonit-26-e925278-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82cc/7580176/63ba804a80f9/medscimonit-26-e925278-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82cc/7580176/1ce3cce26f49/medscimonit-26-e925278-g003.jpg

相似文献

1
Expression of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, and Changes in Alveolar Septa in Patients with Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病患者基质金属蛋白酶-2、基质金属蛋白酶-9、金属蛋白酶组织抑制剂-1的表达及肺泡间隔变化
Med Sci Monit. 2020 Oct 18;26:e925278. doi: 10.12659/MSM.925278.
2
Pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease and therapeutic effects of glucocorticoids and N-acetylcysteine in rats.香烟烟雾诱导的大鼠慢性阻塞性肺疾病的发病机制及糖皮质激素和N-乙酰半胱氨酸的治疗作用
Chin Med J (Engl). 2004 Nov;117(11):1611-9.
3
[Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].[哮喘和慢性阻塞性肺疾病患者诱导痰中金属蛋白酶-9/金属蛋白酶组织抑制剂-1及其与气道炎症和气流受限的关系]
Zhonghua Jie He He Hu Xi Za Zhi. 2007 Mar;30(3):192-6.
4
[Relationships between the expressions of intercellular adhesion molecule-1 and tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 in lung tissues of patients with chronic obstructive pulmonary disease].[慢性阻塞性肺疾病患者肺组织中细胞间黏附分子-1、金属蛋白酶组织抑制剂-1及基质金属蛋白酶-9表达之间的关系]
Zhonghua Jie He He Hu Xi Za Zhi. 2008 Feb;31(2):129-33.
5
Expressions of TOLL-like receptor 4 (TLR-4) and matrix metalloproteinase 9 (MMP-9)/Tissue inhibitor of metalloproteinase 1 (TIMP-1) in pulmonary blood vessels with chronic obstructive pulmonary diseases and their relationships with pulmonary vascular remodelling.慢性阻塞性肺疾病肺血管中Toll样受体4(TLR-4)和基质金属蛋白酶9(MMP-9)/金属蛋白酶组织抑制因子1(TIMP-1)的表达及其与肺血管重塑的关系
Rev Assoc Med Bras (1992). 2018 Apr;64(4):361-367. doi: 10.1590/1806-9282.64.04.361.
6
[The role of matrix metalloproteinases in extracellular matrix remodelling in chronic obstructive pulmonary disease rat models].[基质金属蛋白酶在慢性阻塞性肺疾病大鼠模型细胞外基质重塑中的作用]
Zhonghua Nei Ke Za Zhi. 2002 Jun;41(6):393-8.
7
[Influence of N-acetylcysteine on the cytokines and matrix metalloproteinases in chronic obstructive pulmonary disease rat models].[N-乙酰半胱氨酸对慢性阻塞性肺疾病大鼠模型细胞因子及基质金属蛋白酶的影响]
Zhonghua Nei Ke Za Zhi. 2004 Aug;43(8):595-9.
8
[The role of matrix metalloproteinases-9 and tissue inhibitor of metalloproteinaes-1 in chronic obstructive pulmonary disease].基质金属蛋白酶-9和金属蛋白酶组织抑制剂-1在慢性阻塞性肺疾病中的作用
Zhonghua Yi Xue Za Zhi. 2003 Jul 10;83(13):1138-41.
9
Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者肺泡巨噬细胞释放基质金属蛋白酶-9及金属蛋白酶组织抑制因子-1的情况与活性
Am J Respir Cell Mol Biol. 2002 May;26(5):602-9. doi: 10.1165/ajrcmb.26.5.4685.
10
Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects.慢性阻塞性肺疾病、特发性肺纤维化患者及健康受试者痰液中基质金属蛋白酶-9、金属蛋白酶组织抑制剂-1及其摩尔比
Respir Med. 2003 Jun;97(6):634-9. doi: 10.1053/rmed.2003.1493.

引用本文的文献

1
Increased serum IL‑41 associated with acute exacerbation of chronic obstructive pulmonary disease.血清白细胞介素-41升高与慢性阻塞性肺疾病急性加重相关。
Exp Ther Med. 2024 Jun 5;28(2):312. doi: 10.3892/etm.2024.12601. eCollection 2024 Aug.
2
The TIMP protein family: diverse roles in pathophysiology.TIMP 蛋白家族:在病理生理学中的多种作用。
Am J Physiol Cell Physiol. 2024 Mar 1;326(3):C917-C934. doi: 10.1152/ajpcell.00699.2023. Epub 2024 Jan 29.
3
Inflammation-Associated Lung Tissue Remodeling and Fibrosis in Morphine-Dependent SIV-Infected Macaques.

本文引用的文献

1
Endobronchial Valve Treatment in Emphysema Patients with a Very Low DLCO.肺气肿患者极低 DLCO 时的支气管内瓣膜治疗。
Respiration. 2020;99(2):163-170. doi: 10.1159/000505428. Epub 2020 Jan 21.
2
Participation of the miR-22-HDAC4-DLCO Axis in Patients with COPD by Tobacco and Biomass.miR-22-HDAC4-DLCO 轴在烟草和生物量致 COPD 患者中的作用
Biomolecules. 2019 Dec 6;9(12):837. doi: 10.3390/biom9120837.
3
An Autopsy Case of Pulmonary Capillary Hemangiomatosis with an Electron Microscopy Study.一例肺毛细血管瘤病尸检病例及电镜研究
吗啡依赖的 SIV 感染猴肺部组织炎症相关重塑和纤维化
Am J Pathol. 2023 Apr;193(4):380-391. doi: 10.1016/j.ajpath.2022.12.016.
4
Matrix Metalloproteinases in Chronic Obstructive Pulmonary Disease.基质金属蛋白酶在慢性阻塞性肺疾病中的作用。
Int J Mol Sci. 2023 Feb 14;24(4):3786. doi: 10.3390/ijms24043786.
5
Seed Oil Attenuates LPS-Induced BEAS-2B Cell Activation and Inflammation by Inhibiting the TLR4/MyD88/NF-B Signaling Pathway.种子油通过抑制TLR4/MyD88/NF-κB信号通路减轻脂多糖诱导的BEAS-2B细胞活化和炎症。
Evid Based Complement Alternat Med. 2021 Sep 24;2021:2073296. doi: 10.1155/2021/2073296. eCollection 2021.
6
Structural characterisation of inhibitory and non-inhibitory MMP-9-TIMP-1 complexes and implications for regulatory mechanisms of MMP-9.抑制性和非抑制性 MMP-9-TIMP-1 复合物的结构特征及其对 MMP-9 调控机制的影响。
Sci Rep. 2021 Jun 28;11(1):13376. doi: 10.1038/s41598-021-92881-x.
Am J Case Rep. 2019 Oct 22;20:1551-1557. doi: 10.12659/AJCR.918375.
4
Endotoxin-Induced Emphysema Exacerbation: A Novel Model of Chronic Obstructive Pulmonary Disease Exacerbations Causing Cardiopulmonary Impairment and Diaphragm Dysfunction.内毒素诱导的肺气肿加重:一种导致心肺功能损害和膈肌功能障碍的慢性阻塞性肺疾病加重的新型模型。
Front Physiol. 2019 May 28;10:664. doi: 10.3389/fphys.2019.00664. eCollection 2019.
5
Lung function in children with juvenile idiopathic arthritis: A cross-sectional analysis.儿童幼年特发性关节炎的肺功能:一项横断面分析。
Pediatr Pulmonol. 2019 Aug;54(8):1242-1249. doi: 10.1002/ppul.24360. Epub 2019 May 17.
6
Cathepsin L promotes secretory IgA response by participating in antigen presentation pathways during Mycoplasma Hyopneumoniae infection.组织蛋白酶 L 通过参与肺炎支原体感染期间的抗原呈递途径促进分泌型 IgA 应答。
PLoS One. 2019 Apr 15;14(4):e0215408. doi: 10.1371/journal.pone.0215408. eCollection 2019.
7
Inhibitory effects of total ginsenoside on bleomycin-induced pulmonary fibrosis in mice.总皂苷对博来霉素诱导的小鼠肺纤维化的抑制作用。
Biomed Pharmacother. 2019 Jun;114:108851. doi: 10.1016/j.biopha.2019.108851. Epub 2019 Apr 6.
8
Chronic Obstructive Pulmonary Disease: Evaluation and Management.慢性阻塞性肺疾病:评估与管理。
Med Clin North Am. 2019 May;103(3):453-461. doi: 10.1016/j.mcna.2018.12.005. Epub 2019 Mar 14.
9
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019.全球慢性阻塞性肺疾病诊断、管理和预防策略:GOLD 科学委员会报告 2019.
Eur Respir J. 2019 May 18;53(5). doi: 10.1183/13993003.00164-2019. Print 2019 May.
10
Relationship Between Circulating Serpina3g, Matrix Metalloproteinase-9, and Tissue Inhibitor of Metalloproteinase-1 and -2 with Chronic Obstructive Pulmonary Disease Severity.血清丝氨酸蛋白酶抑制剂 3G、基质金属蛋白酶-9 与组织金属蛋白酶抑制剂-1、-2 与慢性阻塞性肺疾病严重程度的关系。
Biomolecules. 2019 Feb 13;9(2):62. doi: 10.3390/biom9020062.